Triple therapy greatly increases myocardial salvage during ischemia/reperfusion in the in situ rat heart

Cardiovascular Drugs and Therapy

Volumn 27, Issue 5, 2013, Pages 403-412

  Yang, Xi Ming ^a   Cui, Lin ^a   Alhammouri, Ahmad ^a   Downey, James M ^a   Cohen, Michael V ^a  

^a UNIVERSITY OF SOUTH ALABAMA COLLEGE OF MEDICINE   (United States)

Author keywords

Cangrelor; Cardioprotection; Cariporide; Hypothermia; Myocardial infarction; Platelet aggregation; Ticagrelor

Indexed keywords

CANGRELOR; CARIPORIDE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE C; SODIUM CHLORIDE; TICAGRELOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BOLUS INJECTION; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DRUG STRUCTURE; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HYPOTHERMIA; ISCHEMIC PRECONDITIONING; MALE; NONHUMAN; PERITONEUM LAVAGE; PRIORITY JOURNAL; PROTON SODIUM EXCHANGE; RAT; SALVAGE THERAPY; SIGNAL TRANSDUCTION; THROMBOCYTE AGGREGATION;

ADENOSINE; ADENOSINE MONOPHOSPHATE; ANIMALS; ANTI-ARRHYTHMIA AGENTS; CARDIOTONIC AGENTS; GUANIDINES; HYPOTHERMIA, INDUCED; ISCHEMIC PRECONDITIONING, MYOCARDIAL; MALE; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION INJURY; PURINERGIC P2Y RECEPTOR ANTAGONISTS; RATS; RATS, SPRAGUE-DAWLEY; SULFONES;

EID: 84885172325     PISSN: 09203206     EISSN: 15737241     Source Type: Journal    
DOI: 10.1007/s10557-013-6474-9     Document Type: Article

References (38)

1. Kitakaze M, Asakura M, Kim J, Shintani Y, Asanuma H, Hamasaki T, et al. Human atrial natriuretic peptide and nicorandil as adjuncts to reperfusion treatment for acute myocardial infarction (J-WIND): two randomised trials. Lancet. 2007;370:1483-93.
2. Mochly-Rosen D, Grimes KV. Myocardial salvage in acute myocardial infarction-challenges in clinical translation. J Mol Cell Cardiol. 2011;51:451-3.
3. Heusch G. Cardioprotection: chances and challenges of its translation to the clinic. Lancet. 2013;381:166-75.
4. Cohen MV, Downey JM. Is it time to translate ischemic preconditioning's mechanism of cardioprotection into clinical practice? J Cardiovasc Pharmacol Ther. 2011;16:273-80.
5. Patti G, Bárczi G, Orlic D, Mangiacapra F, Colonna G, Pasceri V, et al. Outcome comparison of 600- and 300-mg loading doses of clopidogrel in patients undergoing primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: results from the ARMYDA-6 MI (Antiplatelet therapy for Reducton of MYocardial Damage during Angioplasty-Myocardial Infarction) randomized study. J Am Coll Cardiol. 2011;58:1592-9.
6. Roubille F, Lairez O, Mewton N, Rioufol G, Ranc S, Sanchez I, et al. Cardioprotection by clopidogrel in acute ST-elevated myocardial infarction patients: a retrospective analysis. Basic Res Cardiol. 2012;107:275.
7. 12 blockers confer direct postconditioning-like protection in reperfused rabbit hearts. J Cardiovasc Pharmacol Ther. 2013;18:251-62.
8. Yang X-M, Liu Y, Cui L, Yang X, Liu Y, Tandon N, et al. Two classes of anti-platelet drugs reduce anatomical infarct size in monkey hearts. Cardiovasc Drugs Ther. 2013;27:109-15.
9. Xu Z, Jiao Z, Cohen MV, Downey JM. Protection from AMP 579 can be added to that from either cariporide or ischemic preconditioning in ischemic rabbit heart. J Cardiovasc Pharmacol. 2002;40:510-8.
10. Kristo G, Yoshimura Y, Ferraris SP, Jahania SA, Mentzer Jr RM, Lasley RD. The preischemic combination of the sodium-hydrogen exchanger inhibitor cariporide and the adenosine agonist AMP579 acts additively to reduce porcine myocardial infarct size. J Am Coll Surg. 2004;199:586-94.
11. Miki T, Liu GS, Cohen MV, Downey JM. Mild hypothermia reduces infarct size in the beating rabbit heart: a practical intervention for acute myocardial infarction? Basic Res Cardiol. 1998;93:372-83.
12. Hausenloy DJ, Wynne AM, Yellon DM. Ischemic preconditioning targets the reperfusion phase. Basic Res Cardiol. 2007;102:445-52.
13. National Research Council. Guide for the Care and Use of Laboratory Animals. 7th ed. Washington, DC: National Academy Press; 1996.
14. Yang X-M, Liu Y, Liu Y, Tandon N, Kambayashi J, Downey JM, et al. Attenuation of infarction in cynomolgus monkeys: preconditioning and postconditioning. Basic Res Cardiol. 2010;105:119-28.
15. Sugidachi A, Asai F, Ogawa T, Inoue T, Koike H. The in vivo pharmacological profile of CS-747, a novel antiplatelet agent with platelet ADP receptor antagonist properties. Br J Pharmacol. 2000;129:1439-46.
16. Ytrehus K, Liu Y, Tsuchida A, Miura T, Liu GS, Yang X-M, et al. Rat and rabbit heart infarction: effects of anesthesia, perfusate, risk zone, and method of infarct sizing. Am J Physiol. 1994;267:H2383-90.
17. Staat P, Rioufol G, Piot C, Cottin Y, Cung TT, L'Huillier I, et al. Postconditioning the human heart. Circulation. 2005;112:2143-8.
18. Montalescot G, Wiviott SD, Braunwald E, Murphy SA, Gibson CM, McCabe CH, et al. Prasugrel compared with clopidogrel in patients undergoing percutaneous coronary intervention for ST-elevation myocardial infarction (TRITON-TIMI 38): double-blind, randomised controlled trial. Lancet. 2009;373:723-31.
19. Kohli P, Wallentin L, Reyes E, Horrow J, Husted S, Angiolillo DJ, et al. Reduction in first and recurrent cardiovascular events with ticagrelor compared with clopidogrel in the PLATO study. Circulation. 2013;127:673-80.
20. Tissier R, Hamanaka K, Kuno A, Parker JC, Cohen MV, Downey JM. Total liquid ventilation provides ultra-fast cardioprotective cooling. J Am Coll Cardiol. 2007;49:601-5.
21. Yang X, Liu Y, Yang X-M, Hu F, Cui L, Swingle MR, et al. Cardioprotection by mild hypothermia during ischemia involves preservation of ERK activity. Basic Res Cardiol. 2011;106:421-30.
22. 1 adenosine receptors in rabbit heart. Circulation. 1991;84:350-6.
23. Sibbing D, Bernlochner I, Schulz S, Massberg S, Schömig A, Mehilli J, et al. Prognostic value of a high on-clopidogrel treatment platelet reactivity in bivalirudin versus abciximab treated non-ST-segment elevation myocardial infarction patients: ISAR-REACT 4 (Intracoronary Stenting and Antithrombotic Regimen: Rapid Early Action for Coronary Treatment-4) platelet substudy. J Am Coll Cardiol. 2012;60:369-77.
24. Parodi G, Valenti R, Bellandi B, Migliorini A, Marcucci R, Comito V, et al. Comparison of prasugrel and ticagrelor loading doses in ST-segment elevation myocardial infarction patients: RAPID (Rapid Activity of Platelet Inhibitor Drugs) primary PCI study. J Am Coll Cardiol. 2013;61:1601-6.
25. Mentzer Jr RM, Bartels C, Bolli R, Boyce S, Buckberg GD, Chaitman B, et al. Sodium-hydrogen exchange inhibition by cariporide to reduce the risk of ischemic cardiac events in patients undergoing coronary artery bypass grafting: results of the EXPEDITION study. Ann Thorac Surg. 2008;85:1261-70.
26. Shao Z-H, Sharp WW, Wojcik KR, Li C-Q, Han M, Chang W-T, et al. Therapeutic hypothermia cardioprotection via Akt- and nitric oxide-mediated attenuation of mitochondrial oxidants. Am J Physiol. 2010;298:H2164-73.
27. + exchange inhibitor, Hoe 642: difference from preconditioning in the role of protein kinase C. J Am Coll Cardiol. 1997;29:693-701.
28. + exchange inhibition against ischemia/reperfusion injury. J Am Coll Cardiol. 2001;37:957-63.
29. 2+ overload and PTP opening. Am J Physiol. 2007;293:H3517-23.
30. Chien GL, Wolff RA, Davis RF, VanWinkle DM. "Normothermic range" temperature affects myocardial infarct size. Cardiovasc Res. 1994;28:1014-7.
31. Tissier R, Cohen MV, Downey JM. Protecting the acutely ischemic myocardium beyond reperfusion therapies: are we any closer to realizing the dream of infarct size elimination? Arch Mal Coeur Vaiss. 2007;100:794-802.
32. Karmazyn M. NHE-1: still a viable therapeutic target. J Mol Cell Cardiol. 2013 in press
33. + exchange inhibitors for cardioprotective therapy: progress, problems and prospects. J Am Coll Cardiol. 2002;39:747-53.
34. Kunichika H, Ben-Yehuda O, Lafitte S, Kunichika N, Peters B, DeMaria AN. Effects of glycoprotein IIb/IIIa inhibition on microvascular flow after coronary reperfusion. A quantitative myocardial contrast echocardiography study J Am Coll Cardiol. 2004;43:276-83.
35. Lefer AM, Campbell B, Scalia R, Lefer DJ. Synergism between platelets and neutrophils in provoking cardiac dysfunction after ischemia and reperfusion: role of selectins. Circulation. 1998;98:1322-8.
36. Campbell B, Chuhran CM, Lefer DJ, Lefer AM. Cardioprotective effects of abciximab (ReoPro) in an isolated perfused rat heart model of ischemia and reperfusion. Methods Find Exp Clin Pharmacol. 1999;21:529-34.
37. Freixa X, Bellera N, Ortiz-Pérez JT, Jiménez M, Paré C, Bosch X, et al. Ischaemic postconditioning revisited: lack of effects on infarct size following primary percutaneous coronary intervention. Eur Heart J. 2012;33:103-12.
38. Tarantini G, Favaretto E, Marra MP, Frigo AC, Napodano M, Cacciavillani L, et al. Postconditioning during coronary angioplasty in acute myocardial infarction: the POST-AMI trial. Int J Cardiol. 2012;162:33-8.